Lupus nephritis in children at Sohag Hospital
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study looks at children with lupus nephritis (a kidney problem caused by lupus) to understand what factors affect their disease and outcomes. It may help doctors better treat kids with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child (under 18) with lupus and kidney problems related to lupus.
- You cannot have other rheumatic diseases (like rheumatoid arthritis or still's disease).
- Newborns are not included.
- You cannot have other kidney diseases not caused by lupus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.
This study tests a combination of two medicines, rituximab and low-dose mycophenolate, to treat a type of kidney inflammation called proliferative lupus nephritis in children. It aims to see if the combination works well and is safe for kids with active lupus affecting the kidneys.
This Phase 2 study tests how well the medicine mycophenolate mofetil (MMF) works for children and teens with lupus nephritis that is “proliferative” (a specific biopsy type). You may qualify if your kidney biopsy and current treatment match the study’s targets and you can follow frequent visits and testing.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
This study looks at whether a specific antibody (anti-alpha-actinin) in the blood is linked to active lupus kidney disease. It may help doctors better understand and monitor kidney problems in people with lupus.
This study looks at two simple blood tests to see if they can help doctors understand and predict how lupus-related kidney disease (lupus nephritis) is progressing. The goal is to improve monitoring and treatment decisions for people with this condition.
Hear when a new Lupus Nephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.